06 January 2025
06 January 2025
Evidence suggests “one or fewer drinks per day” may elevate the risk for cancers.
An investor in the US kefir maker, Danone argues Lifeway’s award violated their shareholder agreement.
GLP-1 drugs, such as Wegovy and Ozempic, are gaining popularity in the US and Europe for their appetite-suppressing properties.
The company hopes to begin production of its Lone Star brand at AB InBev’s brewery in Houston in the first quarter of this year.
Spirits industry commentator Richard Woodard weighs up what could lie ahead for gin, RTDs and non-alcoholic alternatives in 2025.
Executives from Pernod Ricard, Heineken, Suntory and Tropicana will speak at the latest conference from Just Drinks’ sister events arm.
Non-alcoholic cocktails is the most popular alcohol-free category in France, the study suggests.
In the 12 months to the end of November, US spirits volumes dipped 0.6%, NABCA figures show.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
